<DOC>
	<DOCNO>NCT02826811</DOCNO>
	<brief_summary>BKV nephropathy ( BKV ) one frequent complication kidney transplantation . In absence specific anti-BKV treatment , pre-emptive reduction immunosuppression main strategy proven effective reduce risk BKVN . However , expose transplant rejection risk estimate 4 14 % accord study . Despite pre-emptive reduction immunosuppression , significant number patient continue progress towards BKVN suggest pre-emptive strategy late . It 's therefore urgent develop new prognostic marker identify earlier effectively patient high risk develop BKVN .</brief_summary>
	<brief_title>Role Anti-BK Virus Neutralizing Antibodies ( BKV ) Prognostic Marker Development Nephropathy BK</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Patient 18 year Grafted kidney patient 1 July 2012 31 July 2014 Strasbourg University Hospital regular monitoring Patient 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Graft dysfunction</keyword>
	<keyword>Graft loss</keyword>
	<keyword>kidney</keyword>
	<keyword>Transplantation</keyword>
	<keyword>BKV</keyword>
	<keyword>Anti-BKV</keyword>
	<keyword>Nephropathy</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Prognostic marker</keyword>
</DOC>